Most lately, it has been discovered that conolidine and the above mentioned derivatives act within the atypical chemokine receptor 3 (ACKR3. Expressed in identical parts as classical opioid receptors, it binds to a wide array of endogenous opioids. Contrary to most opioid receptors, this receptor functions like a scavenger https://harryc679axl2.thechapblog.com/profile